Stability and inactivation of SARS coronavirus.
Stability and inactivation of SARS coronavirus.
复制标题
DOI:
10.1007/s00430-004-0219-0
复制
发表时间:
2005-01
影响因子:
5.4
通讯作者:
Doerr HW
中科院分区:
文献类型:
--
作者:
Rabenau HF;Cinatl J;Morgenstern B;Bauer G;Preiser W;Doerr HW
The SARS-coronavirus (SARS-CoV) is a newly emerged, highly pathogenic agent that caused over 8,000 human infections with nearly 800 deaths between November 2002 and September 2003. While direct person-to-person transmission via respiratory droplets accounted for most cases, other modes have not been ruled out. Faecal shedding is common and prolonged and has caused an outbreak in Hong Kong. We studied the stability of SARS-CoV under different conditions, both in suspension and dried on surfaces, in comparison with other human-pathogenic viruses, including human coronavirus HCoV-229E. In suspension, HCoV-229E gradually lost its infectivity completely while SARS-CoV retained its infectivity for up to 9 days; in the dried state, survival times were 24 h versus 6 days. Thermal inactivation at 56°C was highly effective in the absence of protein, reducing the virus titre to below detectability; however, the addition of 20% protein exerted a protective effect resulting in residual infectivity. If protein-containing solutions are to be inactivated, heat treatment at 60°C for at least 30 min must be used. Different fixation procedures, e.g. for the preparation of immunofluorescence slides, as well as chemical means of virus inactivation commonly used in hospital and laboratory settings were generally found to be effective. Our investigations confirm that it is possible to care for SARS patients and to conduct laboratory scientific studies on SARS-CoV safely. Nevertheless, the agent’s tenacity is considerably higher than that of HCoV-229E, and should SARS re-emerge, increased efforts need to be devoted to questions of environmental hygiene.
登录
查看更多内容
影响因子:
13.6
作者:
Drosten C;Preiser W;Günther S;Schmitz H;Doerr HW
通讯作者:
Doerr HW
DOI:
10.1016/s0140-6736(03)13168-6
发表时间:
2003-05-03
期刊:
Lancet (London, England)
影响因子:
--
作者:
Seto WH;Tsang D;Yung RW;Ching TY;Ng TK;Ho M;Ho LM;Peiris JS;Advisors of Expert SARS group of Hospital Authority
通讯作者:
Advisors of Expert SARS group of Hospital Authority
DOI:
10.1053/jhin.2000.0795
发表时间:
2000-09
期刊:
The Journal of hospital infection
影响因子:
--
作者:
Sizun J;Yu MW;Talbot PJ
通讯作者:
Talbot PJ
影响因子:
5.6
作者:
Snijder EJ;Bredenbeek PJ;Dobbe JC;Thiel V;Ziebuhr J;Poon LL;Guan Y;Rozanov M;Spaan WJ;Gorbalenya AE
通讯作者:
Gorbalenya AE
DOI:
10.1016/s0140-6736(03)13412-5
发表时间:
2003-05-24
期刊:
Lancet (London, England)
影响因子:
--
作者:
Peiris JS;Chu CM;Cheng VC;Chan KS;Hung IF;Poon LL;Law KI;Tang BS;Hon TY;Chan CS;Chan KH;Ng JS;Zheng BJ;Ng WL;Lai RW;Guan Y;Yuen KY;HKU/UCH SARS Study Group
通讯作者:
HKU/UCH SARS Study Group